[1] Mason C, Dooley N, Griffiths M. Acute respiratory distress syndrome. Clin Med (Lond). 2017;17(5):439-43. doi: 10.7861/clinmedicine.17-5-439.
[2] McNicholas BA, Rooney GM, Laffey JG. Lessons to learn from epidemiologic studies in ARDS. Curr Opin Crit Care. 2018;24(1):41-8. doi: 10.1097/MCC.0000000000000473.
[3] Herrero R, Sanchez G, Lorente JA. New insights into the mechanisms of pulmonary edema in acute lung injury. Ann Transl Med. 2018;6(2):32. doi: 10.21037/atm.2017.12.18.
[4] Fan EKY, Fan J. Regulation of alveolar macrophage death in acute lung inflammation. Respir Res. 2018;19(1):50. doi: 10.1186/s12931-018-0756-5.
[5] Yu SY, Tang L, Zhou SH. Long Noncoding RNAs: New Players in Ischaemia-Reperfusion Injury. Heart Lung Circ. 2018;27(3):322-32. doi: 10.1016/j.hlc.2017.09.011. Epub 2017 Oct 12.
[6] Li W, Qiu X, Jiang H, Han Y, Wei D, Liu J. Downregulation of miR-181a protects mice from LPS-induced acute lung injury by targeting Bcl-2. Biomed Pharmacother. 2016;84:1375-82. doi: 10.1016/j.biopha.2016.10.065. Epub 2016 Oct 29.
[7] McKiernan PJ, Greene CM. High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease. Expert Rev Mol Diagn. 2016;16(2):173-85. doi: 10.1586/14737159.2016.1122526. Epub 2015 Dec 10.
[8] Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344-52. doi: 10.1038/nature12986.
[9] Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011;147(7):1537-50. doi: 10.1016/j.cell.2011.11.055.
[10] Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71(20):6320-6. doi: 10.1158/0008-5472.CAN-11-1021. Epub 2011 Aug 23.
[11] Guttman M, Rinn JL. Nature. Modular regulatory principles of large non-coding RNAs. 2012;482(7385):339-46. doi: 10.1038/nature10887.
[12] Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031-41.
[13] Lelli A, Nolan KA, Santambrogio S, Gonçalves AF, Schönenberger MJ, Guinot A, Frew IJ, Marti HH, Hoogewijs D, Wenger RH. Induction of long noncoding RNA MALAT1 in hypoxic mice. Hypoxia (Auckl). 2015;3:45-52. eCollection 2015.
[14] Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, John D Ponomareva Y, Chen W, Uchida S, Boon RA, Dimmeler S. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014;114(9):1389-97. doi: 10.1161/CIRCRESAHA.114.303265.
[15] Li X, Zeng L, Cao C, Lu C, Lian W, Han J, Zhang X, Zhang J, Tang T, Li M. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327-35. doi: 10.1016/j.yexcr.2016.12.006.
[16] Dai L, Zhang G, Cheng Z, Wang X, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, Yang Y, Yang M. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury. Connect Tissue Res. 2018;59(6):581-92. doi: 10.1080/03008207.2018.1439480.
[17] Li H, Shi H, Ma N, Zi P, Liu Q, Sun R. BML-111 alleviates acute lung injury through regulating the expression of lncRNA MALAT1. Arch Biochem Biophys. 2018;649:15-21. doi: 10.1016/j.abb.2018.04.016.
[18] ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526-33. doi: 10.1001/jama.2012.5669.
[19] Li TJ, Zhao LL, Qiu J, Zhang HY, Bai GX, Chen L. Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-κB pathway in LPS-induced acute lung injury. Mol Med Rep. 2017;16(2):2225-32. doi: 10.3892/mmr.2017.6837.
[20] An S, Hishikawa Y, Liu J, Koji T. Lung injury after ischemia-reperfusion of small intestine in rats involves apoptosis of type II alveolar epithelial cells mediated by TNF-alpha and activation of Bid pathway. Apoptosis. 2007;12(11):1989-2001.
[21] McGuigan RM, Mullenix P, Norlund LL, Ward D, Walts M, Azarow K. Acute lung injury using oleic acid in the laboratory rat: establishment of a working model and evidence against free radicals in the acute phase. Curr Surg. 2003;60(4):412-7.
[22] Dekker BG, Arts CJ, De Ligny CL. Gel-chromatographic analysis of 99mTc-labeled human serum albumin prepared with Sn(II) as the reductant. Int J Appl Radiat Isot. 1982;33(12):1351-7.
[23] Xin JW, Jiang YG. Long noncoding RNA MALAT1 inhibits apoptosis induced by oxygen-glucose deprivation and reoxygenation in human brain microvascular endothelial cells. Exp Ther Med. 2017;13(4):1225-34. doi: 10.3892/etm.2017.4095.
[24] Wang G, Wu Y, Zhu Y. Mechanism of MALAT1 preventing apoptosis of vascular endothelial cells induced by oxygen-glucose deficiency and reoxidation. Artif Cells Nanomed Biotechnol. 2018;46(sup1):798-805. doi: 10.1080/21691401.2018.1436065.
[25] Li Z, Xu C, Ding B, Gao M, Wei X4, Ji N. Long non-coding RNA MALAT1 promotes proliferation and suppresses apoptosis of glioma cells through derepressing Rap1B by sponging miR-101. J Neurooncol. 2017;134(1):19-28. doi: 10.1007/s11060-017-2498-5.
[26] Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3-11. doi: 10.1055/s-0034-1397344.
[27] Yang L, Ma Y, Xin Y, Han R, Li R, Hao X. Role of the microRNA 181 family in glioma development. Mol Med Rep. 2018;17(1):322-9. doi: 10.3892/mmr.2017.7895.
[28] Sharp C, Millar AB, Medford AR. Advances in understanding of the pathogenesis of acute respiratory distress syndrome. Respiration. 2015;89(5):420-34. doi: 10.1159/000381102.
[29] Zhuang YT, Xu DY, Wang GY, Sun JL, Huang Y, Wang SZ. IL-6 induced lncRNA MALAT1 enhances TNF-α expression in LPS-induced septic cardiomyocytes via activation of SAA3. Eur Rev Med Pharmacol Sci. 2017;21(2):302-9.
[30] Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878-88. doi: 10.1016/j.bbamcr.2011.01.034.
[31] Sishi BJ, Engelbrecht AM. Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes. Cytokine. 2011;54(2):173-84. doi: 10.1016/j.cyto.2011.01.009.
[32] Aitken SL, Corl CM, Sordillo LM. Pro-inflammatory and pro-apoptotic responses of TNF-α stimulated bovine mammary endothelial cells. Vet Immunol Immunopathol. 2011;140(3-4):282-90. doi: 10.1016/j.vetimm.2011.01.016.
[33] Qiu B, Gong M, He QT, Zhou PH. Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes. Biomed Res Int. 2016;2016:6290957.